Single-cell landscapes of primary glioblastomas and matched organoids and cell lines reveal variable retention of inter- and intra-tumor heterogeneity

Glioblastomas (GBMs) are aggressive primary malignant brain tumors characterized by extensive levels of inter- and intra-tumor genetic and phenotypic heterogeneity. Patient-derived organoids (PDOs) have recently emerged as useful models to study such heterogeneity. Here, we present bulk exome as well as single-cell genome and transcriptome profiles of primary IDH wild type GBMs from ten patients, including two recurrent tumors, as well as PDOs and brain tumor-initiating cell (BTIC) lines derived from these patients. We find that PDOs are genetically similar to and variably retain gene expression characteristics of their parent tumors. At the phenotypic level, PDOs appear to exhibit similar levels of transcriptional heterogeneity as their parent tumors, whereas BTIC lines tend to be enriched for cells in a more uniform transcriptional state. The datasets introduced here will provide a valuable resource to help guide experiments using GBM-derived organoids, especially in the context of studying cellular heterogeneity.

[1]  Anna Luisa Di Stefano,et al.  Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities , 2021, Nature Cancer.

[2]  S. Weiss,et al.  Single-cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survival , 2021, eLife.

[3]  Gary D Bader,et al.  Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity , 2021, Nature Cancer.

[4]  S. Bicciato,et al.  Single-cell analyses reveal YAP/TAZ as regulators of stemness and cell plasticity in Glioblastoma , 2020, Nature Cancer.

[5]  C. Kuo,et al.  Organoid Models of Tumor Immunology , 2020, Trends in immunology.

[6]  Kevin Petrecca,et al.  Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy , 2020, Nature Communications.

[7]  Raymond Y Huang,et al.  Mechanisms and therapeutic implications of hypermutation in gliomas , 2020, Nature.

[8]  Madeline G. Andrews,et al.  Outer Radial Glia-like Cancer Stem Cells Contribute to Heterogeneity of Glioblastoma. , 2020, Cell stem cell.

[9]  Zev A. Binder,et al.  A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity , 2019, Cell.

[10]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[11]  Kristian Cibulskis,et al.  Calling Somatic SNVs and Indels with Mutect2 , 2019, bioRxiv.

[12]  Arnold Kriegstein,et al.  The phenotypes of proliferating glioblastoma cells reside on a single axis of variation. , 2019, Cancer discovery.

[13]  Richard A. Moore,et al.  Clonal Decomposition and DNA Replication States Defined by Scaled Single-Cell Genome Sequencing , 2019, Cell.

[14]  Michael Hahsler,et al.  dbscan: Fast Density-Based Clustering with R , 2019, Journal of Statistical Software.

[15]  Margaret E. Roberts,et al.  stm: An R Package for Structural Topic Models , 2019, Journal of Statistical Software.

[16]  Mariella G. Filbin,et al.  An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma , 2019, Cell.

[17]  B. Kálmán,et al.  Longitudinal Characteristics of Glioblastoma in Genome-Wide Studies , 2019, Pathology & Oncology Research.

[18]  Olga Tanaseichuk,et al.  Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.

[19]  H. Fine,et al.  Modeling Patient-Derived Glioblastoma with Cerebral Organoids. , 2019, Cell reports.

[20]  Atul J. Butte,et al.  Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage , 2018, Nature Immunology.

[21]  Ville Mustonen,et al.  The repertoire of mutational signatures in human cancer , 2018, Nature.

[22]  R. Weinberg,et al.  New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer , 2018, Nature Reviews Molecular Cell Biology.

[23]  J. Ragoussis,et al.  Single-cell RNA-seq reveals that glioblastoma recapitulates normal brain development , 2018, bioRxiv.

[24]  Jill S Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015. , 2018, Neuro-oncology.

[25]  Leland McInnes,et al.  UMAP: Uniform Manifold Approximation and Projection , 2018, J. Open Source Softw..

[26]  Christopher T. Saunders,et al.  Strelka2: fast and accurate calling of germline and somatic variants , 2018, Nature Methods.

[27]  Quanhu Sheng,et al.  Quantitative assessment of cell population diversity in single-cell landscapes , 2018, bioRxiv.

[28]  Inder M Verma,et al.  Glioblastoma Model Using Human Cerebral Organoids , 2018, Cell reports.

[29]  M. Hayden Gephart,et al.  Single-Cell RNA-Sequencing in Glioma , 2018, Current Oncology Reports.

[30]  Leland McInnes,et al.  UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction , 2018, ArXiv.

[31]  S. Shah,et al.  Observing Clonal Dynamics across Spatiotemporal Axes: A Prelude to Quantitative Fitness Models for Cancer. , 2018, Cold Spring Harbor perspectives in medicine.

[32]  A. Shaw,et al.  Tumour heterogeneity and resistance to cancer therapies , 2018, Nature Reviews Clinical Oncology.

[33]  Alan W Leung,et al.  Next generation organoids for biomedical research and applications. , 2017, Biotechnology advances.

[34]  Richard A. Moore,et al.  Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer , 2017, Clinical Cancer Research.

[35]  A. Kriegstein,et al.  Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment , 2017, Genome Biology.

[36]  Steven D Chang,et al.  Single-Cell RNAseq analysis of infiltrating neoplastic cells at the migrating front of human glioblastoma , 2017, bioRxiv.

[37]  E. Voest,et al.  Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery. , 2017, Cell chemical biology.

[38]  Edward F. Chang,et al.  Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. , 2017, Cancer cell.

[39]  Deric M. Park,et al.  Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells , 2017, Neuro-oncology.

[40]  In-Hee Lee,et al.  Spatiotemporal genomic architecture informs precision oncology in glioblastoma , 2017, Nature Genetics.

[41]  Mariella G. Filbin,et al.  Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq , 2017, Science.

[42]  Lin He,et al.  In-depth comparison of somatic point mutation callers based on different tumor next-generation sequencing depth data , 2016, Scientific Reports.

[43]  Davis J. McCarthy,et al.  A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor , 2016, F1000Research.

[44]  Evan Z. Macosko,et al.  Comprehensive Classification of Retinal Bipolar Neurons by Single-Cell Transcriptomics , 2016, Cell.

[45]  J. Marioni,et al.  Pooling across cells to normalize single-cell RNA sequencing data with many zero counts , 2016, Genome Biology.

[46]  D. Schiff,et al.  Culture conditions tailored to the cell of origin are critical for maintaining native properties and tumorigenicity of glioma cells. , 2016, Neuro-oncology.

[47]  Qiulian Wu,et al.  A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo. , 2016, Cancer research.

[48]  Steven J. M. Jones,et al.  Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma , 2016, Cell.

[49]  Sean C. Bendall,et al.  Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis , 2015, Cell.

[50]  Nilgun Donmez,et al.  Clonality inference in multiple tumor samples using phylogeny , 2015, Bioinform..

[51]  G. Frezza,et al.  Pathological spectrum in recurrences of glioblastoma multiforme. , 2015, Pathologica.

[52]  K. Smetana,et al.  Effect of cancer-associated fibroblasts on the migration of glioma cells in vitro , 2015, Tumor Biology.

[53]  Sohrab P. Shah,et al.  TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data , 2014, Genome research.

[54]  Gelareh Zadeh,et al.  GBM's multifaceted landscape: highlighting regional and microenvironmental heterogeneity. , 2014, Neuro-oncology.

[55]  Shawn M. Gillespie,et al.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.

[56]  J. C. Love,et al.  EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing. , 2014, Cancer discovery.

[57]  Philippe Menei,et al.  Glioblastoma‐associated stromal cells (GASCs) from histologically normal surgical margins have a myofibroblast phenotype and angiogenic properties , 2014, The Journal of pathology.

[58]  A. Bouchard-Côté,et al.  PyClone: statistical inference of clonal population structure in cancer , 2014, Nature Methods.

[59]  M. Sanson,et al.  Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients , 2014, Journal of Neuro-Oncology.

[60]  D. Haussler,et al.  The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.

[61]  Heng Li Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.

[62]  Michael Weller,et al.  Standards of care for treatment of recurrent glioblastoma--are we there yet? , 2013, Neuro-oncology.

[63]  Pablo Cingolani,et al.  © 2012 Landes Bioscience. Do not distribute. , 2022 .

[64]  Martin Kircher,et al.  Addressing challenges in the production and analysis of illumina sequencing data , 2011, BMC Genomics.

[65]  S. Pastorino,et al.  Transdifferentiation of glioblastoma cells into vascular endothelial cells , 2011, Proceedings of the National Academy of Sciences.

[66]  S. Gabriel,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.

[67]  A. Brodbelt,et al.  Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy , 2009, British Journal of Cancer.

[68]  Jean-Loup Guillaume,et al.  Fast unfolding of communities in large networks , 2008, 0803.0476.